Skip to content

Released May 13, 2022, during market hours

10-Q filed May 13, 2022, 43 days after period end · 0001493152-22-013346

Q1 2022 · 10-Q
Revenue$47.53M+211.3% vs Q1 2021+5.3% vs Q4 2021
Net Income$12.49M+1,082.0% vs Q1 2021+18.0% vs Q4 2021
EPS Diluted$0.68+1,033.3% vs Q1 2021no prior Q4 2021 on file
Gross Profit$28,677,000+221.2%
Operating Income$16,146,000+1,222.4%
Operating Cash Flow$20,287,000N/M
Free Cash Flowderived$19,192,000N/M
Margins · derived
Gross margin60.3%+1.9 pt vs Q1 2021
Operating margin34.0%+26.0 pt vs Q1 2021
Net margin26.3%+19.4 pt vs Q1 2021

What the release said

The release

Same quarter

MetricQ1 2022Q1 2021Q1 2020Q1 2019
Revenue$47.53M$15.27M$1.89M$2.32M
Net Income$12.49M$1.06M-$809.00K-$1.01M
EPS Diluted$0.68$0.06-$0.07-$0.09

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR